Growth Opportunity Small to mid-sized medical device company with $1M-$10M revenue and a recent leadership expansion signals a pivot toward scaled field deployment; potential for enterprise-grade field testing programs, pilot deals with hospitals, and collaboration opportunities with trauma centers.

Trauma & ED Focus Product aims to rapid brain bleed detection for field, emergency departments, and hospital settings, aligning with trauma centers and EDs. Target hospitals and Level 1 trauma centers for pilot programs and integration with existing acute care workflows.

Strategic Partnerships Longstanding collaboration with University of Cincinnati Medical Center and local healthcare investors indicate a strong track record and credibility; leverage for joint development, clinical validation, and co-marketing with major academic and regional healthcare networks.

Commercialization Strength Recent hires for Chief Executive Officer and Chief Commercial Officer show a push to scale commercialization, sales processes, and market access; engage in conversations around distribution partnerships, direct sales, and channel strategies in the US market.

Funding & Validation Overall funding of fourteen million and ongoing press coverage plus non-FDA approved status suggests a need for clear regulatory and reimbursement pathways; offer guidance on health economics, reimbursement coding, and strategic investors to accelerate adoption and scale.